RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
about
Targeting BRAF in thyroid cancerTargeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what's new and what's enoughThe RET/PTC3 oncogene activates classical NF-κB by stabilizing NIKModulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTCUpdate: the status of clinical trials with kinase inhibitors in thyroid cancerCurrent concepts and future directions in differentiated thyroid cancer.New insights into the diagnosis of nodular goiter.Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies.MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivoMolecular pathogenesis and mechanisms of thyroid cancerA case of papillary thyroid carcinoma in struma ovarii and review of the literatureHigh rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinomaEndocrine side effects of broad-acting kinase inhibitors.Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinomaClinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancerTargeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer.The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?Recent advances in molecular diagnosis of thyroid cancer.Gain of chromosome band 7q11 in papillary thyroid carcinomas of young patients is associated with exposure to low-dose irradiationmiR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.Hypoxia-inducible factor in thyroid carcinomaThe role of epigenetic alterations in papillary thyroid carcinogenesis.Targeted treatment of differentiated and medullary thyroid cancer.Src inhibitors in suppression of papillary thyroid carcinoma growth.BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature ReviewOrthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAFGenetic and biochemical alterations in non-small cell lung cancer.Modeling thyroid cancer in the mouse.Cancer genes in lung cancer: racial disparities: are there any?The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort StudySRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.Recent advances in molecular biology of thyroid cancer and their clinical implications.Phase II trial of sorafenib in advanced thyroid cancer.Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E).The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation.BRAFV600E Mutation: Has It a Role in Cervical Lymph Node Metastasis of Papillary Thyroid Cancer?Molecular markers of aggressiveness of thyroid cancer.Association between expression of X-linked inhibitor of apoptosis protein and the clinical outcome in a BRAF V600E-prevalent papillary thyroid cancer population.Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer.The quest for diagnostic molecular markers for thyroid nodules with indeterminate or suspicious cytology.
P2860
Q24653496-706C67F6-0008-4076-9D7B-314CA584131CQ26799467-60B9FD31-8916-4E14-91F9-A593B062FE5BQ28511823-F1994866-B5B2-4F76-BDDC-D565C5A7B9F4Q33337251-2E94C970-D2F9-4333-B38E-644DC2F550E3Q33570056-302FCE9C-79B6-48A3-A509-1C5B59774E6BQ33677589-8E66DC1E-1328-47EC-BE35-2E2AC37DE38BQ33827492-DBAF3AC6-F416-4DD1-A12D-9359415D6502Q33984801-402F554D-0B95-4178-A676-D3828578E87FQ34109756-96D07A9D-B9AA-41E0-8B78-41155F3A0B7EQ34329018-552BAC95-E1F8-4C8B-A3B7-0034D609D86DQ34346664-EBF04ECB-50E3-45F7-858F-785921A6E7F8Q34572289-886A36C2-82AB-48FB-ACF9-CF63602C9D0BQ34574985-CA77CF7D-8EBA-489D-A134-990A790A138AQ34588501-38B2A8A5-6551-41D0-BB86-1D3CB59A0EA6Q34595104-ACD55283-1A4A-406D-9FE7-358495F603B2Q34776121-CCAA367A-1443-41D3-824B-5031A859B5F2Q34781888-274266C9-96E3-418D-B05C-C0893C389CAAQ34985320-11DF7CAA-2915-49D7-BAE8-B4A912E90049Q35035094-99321A59-0E5B-4E1F-931C-8CCE964FB395Q35055042-55A55933-6F7C-452A-9A57-16A3B758F294Q35099457-0F08FCDE-A1DF-42BC-BF44-AD6E7B790856Q35099482-1C9792A1-C529-4792-AB00-1E57B5E7D04DQ35147151-CF7A32AE-87F8-4191-B34C-5956604997DBQ35457965-27B2033D-4758-467A-A7DC-0506E19F8756Q35609167-97FBA9DD-1AA7-42FB-BEFA-8A017CDCBFD4Q35914464-D513DD98-1DBB-47B3-ACC4-B5F4E9E5B59EQ36184584-362E8720-798B-450C-A462-E36C80DB5402Q36297044-6513D009-766C-4CC7-8FE4-0B04ACFD33CCQ36481954-F020EBEF-5D4E-4863-831D-4FDE5C7B6958Q36580921-A083CB8E-B551-4626-BCB9-DD6AF7BFF2DEQ36817184-902DC42E-D965-4CEF-8A35-672F00637CEDQ37041330-F2D48AA6-9A3C-4A9A-8D26-BA09A32715CAQ37121708-37B01B22-C06D-4B53-A37A-99CE26F4C133Q37270522-BC79AADF-D7B2-484D-9343-FA6847782D53Q37351482-3357A59A-7859-4290-BCD5-E4D342387611Q37387877-097AC30C-29B5-47EA-9572-0242EBD6C79BQ37544168-C8CCB0B4-AC6C-4A43-A92E-4BAD82339403Q37712610-D395147D-3209-44F1-BFA5-7E591D4D1EB6Q37767709-72B31B99-436D-467D-9236-5C81C6AEE6FFQ37996353-80EB9630-07BD-4DD8-99AB-0C9A50F8243B
P2860
RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
@ast
RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
@en
RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
@nl
type
label
RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
@ast
RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
@en
RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
@nl
prefLabel
RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
@ast
RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
@en
RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
@nl
P356
P1433
P1476
RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
@en
P2093
Yuri E Nikiforov
P304
P356
10.1210/EN.2006-0921
P407
P577
2006-08-31T00:00:00Z